extract from an article on Seeking Alpha
For the pediatric trial, however, there is really nothing left to discuss. The trial was a failure. How much of an effect the pediatric Rett data will have on the rest of the pipeline is anyone's guess, but for now, the stock has taken a terrible beating, going down losing 40% overnight.The company did try to explain the poor show by claiming a very strong placebo effect, but their reasons sounded hollow.
- Forums
- ASX - By Stock
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
extract from an article on Seeking Alpha For the pediatric...
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.71 |
Change
0.000(0.00%) |
Mkt cap ! $2.644B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 269 | $21.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.37 | 10 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 123 | 21.740 |
1 | 500 | 21.500 |
1 | 50 | 21.120 |
2 | 23031 | 21.000 |
2 | 6 | 20.910 |
Price($) | Vol. | No. |
---|---|---|
20.370 | 10 | 1 |
20.500 | 87 | 1 |
20.710 | 50 | 1 |
20.800 | 443 | 2 |
21.000 | 1500 | 1 |
Last trade - 12.16pm 23/05/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online